Treatment for advanced melanoma has seen success with targeted therapies — drugs that interfere with division and growth of cancer cells by
targeting key molecules — especially when multiple drugs are used in combination.
By giving patients an antibody
targeting a key molecule in the inflammatory pathway, investigators reduced heart disease and stroke by 15 %, they reported last week.
Not exact matches
The Company focuses on discovering and developing small
molecule drugs directed against tumor and immune cell
targets that control
key metabolic pathways in the tumor microenvironment.
«A molecular atlas of calcific aortic valve disease: Study builds molecular networks of calcific aortic valve disease to identify
key molecules and therapeutic
targets for a disease that affects one in four older Americans.»
Lanza also designed the nanoparticles to carry
targeting molecules that home in on and bind to cancer cells that carry the complementary receptor, like a lock and
key.
Researchers at the University of Leeds have made a new synthetic anti-cancer
molecule that
targets two
key mechanisms in the spread of malignant tumors through the body.
«This is a seminal step in identifying
key pathways and
molecules involved in kidney cancer so that specific therapies that
target these new genes can be developed to treat this cancer.»
Draths and Frost
targeted this
molecule as the
key to making adipic acid.
The mutations inhibited
key molecules involved in insulin signaling (IIS) and the nutrient signaling pathway
Target of Rapamycin (TOR).
Her group is actively working to identify new
molecules key to the disease process that could become potential drug
targets.
One of the
key parameters in these simulation models are absolute cross sections, which give the probability of interaction between a single LEE and a
target molecule.
But by eliminating the sugar
molecule, the new mutation also affects «a
key region in the virus that is
targeted by the immune system,» Hensley adds, making the vaccine less effective.
A
key finding of AIDS research is that infection begins when HIV binds to a
molecule called CD4 on the
target cell.
«The goal of our research is to identify
key molecules that govern metastasis and use them as
targets for the development of new drugs.»
«Ovarian cancer
target molecule may be
key to blocking its spread.»
A
key problem with the current system is that companies tend to work in parallel, identifying similar or identical
targets and developing their own
molecules — unaware of other similar products that have already been tested and discarded.
Specific Aim 2: Having utilized mutant mice to identify the
key players in AMD pathology from Specific Aim 1, we will develop and test
molecules that
target either the anaphylatoxins or the MAC, or both, in the context of practical therapies that can be utilized in humans.
Enhancing the stability of siRNA
molecules is
key to ensuring that they reach
target cells intact and able to effectively carry out their function.
Our group has 3 major goals: Develop novel therapeutic approaches based on centrosomal clustering To further develop our first prototype inhibitors of centrosomal clustering preclinically and to establish a robust and specific high throughput small
molecule screen Discover
key events in myeloma pathogenesis To investigate the pivotal transition from the pre-malignant, asymptomatic to malignant, symptomatic stages of plasma cell dyscrasias in order to understand the pathophysiology and thereby identify novel
targets Translate small
molecule therapeutics from bench to clinical trials To evaluate novel agents in the preclinical setting and to initiate early phase clinical trials in hematologic malignancies with focus on multiple myeloma
Altogether, our results demonstrate that kahweol is a potent anti-angiogenic compound both in vitro and in vivo,
targeting some
key steps shared with tumor progression,
key molecules involved in ECM remodeling (MMP - 2 and uPA), and
key molecules involved in inflammation (COX - 2 and MCP - 1).
We also demonstrate the inhibitory effect of kahweol on the endothelial cell potential to remodel extracellular matrix by
targeting two
key molecules involved in the process, MMP - 2 and uPA.
The drug, marketed as Lucentis,
targets a
molecule called vascular endothelial growth factor (VEGF), a
key player in the growth of blood vessels.